Table 4.
Group A (n = 34) | Group B (n = 20) | Group C (n = 32) | |
---|---|---|---|
Hematological AE | 2 (6) | 0 (0) | 3 (9) |
Nonhematological AE | 19 (56) | 2 (10) | 9 (28) |
Grade 3 AE | 2 (6) | 0 (0) | 3 (9) |
Discontinuation due to AE | 2 (6) | 2 (10) | 2 (6) |
Values are n (%). AE, adverse events.